Upgrade to SI Premium - Free Trial

Gilead (GILD) Announces Japan's MHLW Approved its Biktarvy for Treatment of HIV-1 Infection

March 26, 2019 8:32 AM
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles